Company Filing History:
Years Active: 2013-2014
Title: The Innovations of James Paul McCall
Introduction
James Paul McCall is an accomplished inventor based in Grafton, WV (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of stabilized formulations of tolterodine tartrate. With a total of 2 patents to his name, McCall's work has the potential to impact various dosage forms in the pharmaceutical industry.
Latest Patents
McCall's latest patents focus on the stabilization of tolterodine L-tartrate formulations. The first patent describes a method of making a pharmaceutical composition containing tolterodine L-tartrate that is stabilized against degradation with an acid. This acid-stabilized tolterodine L-tartrate can be utilized as an active ingredient in various immediate release and controlled release dosage forms, including tablets, capsules, and beads. The second patent also emphasizes a pharmaceutical composition that contains tolterodine L-tartrate stabilized against degradation with an acid, further highlighting its versatility in creating different types of dosage forms.
Career Highlights
Throughout his career, McCall has worked with notable companies in the pharmaceutical sector, including Mylan GmbH and Mylan Pharmaceuticals Inc. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.
Collaborations
Some of McCall's coworkers include David T Rossi and Boyong Li, who have likely contributed to his innovative work in the pharmaceutical field.
Conclusion
James Paul McCall's contributions to the pharmaceutical industry through his patents on tolterodine tartrate formulations demonstrate his commitment to innovation and improvement in drug delivery systems. His work continues to pave the way for advancements in pharmaceutical compositions.